# Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury

> **NCT02882373** · PHASE2 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Drug-Induced Nephropathy
- Hypertension
- Proteinuria

## Interventions

- **DIETARY_SUPPLEMENT:** Arginine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02882373
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10-23
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-05-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Principal Investigator's Request
- **Last updated:** 2019-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02882373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02882373, "Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02882373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*